Table 4 Summary of AEs.

From: Effect of SGLT-2 inhibitor, empagliflozin, on blood pressure reduction in Chinese elderly hypertension patients with type 2 diabetes and its possible mechanisms

 

Placebo

n = 62

Empagliflozin

n = 62

Hypoglycemia

6 (9.7)

9 (14.5)

Events consistent with urinary tract infection

Male

1 (1.6)

1 (1.6)

Female

3 (4.8)

5 (8.1)

Events consistent with genital infection

Male

1 (1.6)

6 (9.7)

Female

0

4 (6.5)

Events consistent with volume depletion

0

1 (1.6)